Radioprotectors in treatment therapy to reduce risk in secondary tumor induction

Pharmacol Ther. 1988;39(1-3):21-5. doi: 10.1016/0163-7258(88)90035-6.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amifostine / therapeutic use
  • Animals
  • Cell Transformation, Neoplastic / drug effects
  • Cell Transformation, Neoplastic / radiation effects
  • Humans
  • Mercaptoethylamines / therapeutic use
  • Neoplasms / radiotherapy*
  • Neoplasms, Radiation-Induced / prevention & control*
  • Radiation-Protective Agents / therapeutic use*

Substances

  • Mercaptoethylamines
  • Radiation-Protective Agents
  • N-(2-mercaptoethyl)-1,3-diaminopropane
  • Amifostine